Future of Healthcare

← Back to Schedule

SESSION:

The panel will focus on the following topics in our exploration of the trends, obstacles and anticipated highlights that we will all face as we interact with the healthcare system in the next decade:

> Digital Therapeutics and the prevalence of computer technology in the delivery of care
> Precision Medicine – what will it look like in a decade, and can we afford it?
> Pharmaceuticals – Bending the cost curve without destroying the drive for innovation
> Creating a sustainable marketplace for universal healthcare insurance

MODERATOR:

Dr. Jeff Hausfeld
Chairman of the Board and Chief Medical Officer at BioFactura, Inc.
Jeffrey Hausfeld, M.D., M.B.A., F.A.C.S., has served on the national board and committees of specialty medical societies since he began his practice in Otolaryngology/Facial Plastic Surgery in 1982. He is an Associate Clinical Professor of Surgery at George Washington University School of Health Sciences and an alumnus of the Yale University School of Medicine. Read full profile…

PANEL:

Bikram Bakshi
Entrepreneur / Investor / Adviser
Bikram is a seasoned CEO, innovator, and entrepreneur based in the Washington, DC area. He has led organizations ranging from early stage startups to key business divisions of a Fortune 10 company. He currently serves on the Entrepreneurship Advisory Board for the Wharton School of the University of Pennsylvania, and is a named inventor of 13 US patents. Read full profile…

Anand Iyer PhD
Chief Strategy Officer
Anand is a respected global digital health leader—most known for his insights on and experience with technology, strategy and regulatory policy. Anand has been instrumental in Welldoc’s success and the development of BlueStar®, the first FDA-cleared mobile prescription therapy for adults with type 2 diabetes. Read full profile…

Kristi Jones PharmD
Chief Operating Officer, NexImmune, Inc
Kristi Jones brings more than 25 years of business leadership experience in the biotech and pharmaceutical industries across strategic and operational roles. For five years prior to joining NexImmune, Ms. Jones was with Astra Zeneca and its subsidiary MedImmune. Read full profile…